INDEMNIFICATION AGREEMENTIndemnification Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of July [___], 2016 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and [___________](“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • January 7th, 2013 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 7th, 2013 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of December 31, 2012 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 22nd, 2008 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 22nd, 2008 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of July 16, 2008 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Andrew J. Ferrara (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • May 14th, 2008 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2008 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of May 12, 2008, by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and John C. Wright (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 14th, 2007 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 14th, 2007 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of October 18, 2007 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Anthony C. Celeste (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 20th, 2006 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 20th, 2006 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of September 7, 2006 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Tim Maudlin (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 20th, 2006 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 20th, 2006 Company Industry JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of September 7, 2006 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Sue Molina (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 19th, 2006 • Sucampo Pharmaceuticals, Inc. • Delaware
Contract Type FiledJune 19th, 2006 Company JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of May 26, 2004 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Hidetoshi Mine (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 19th, 2006 • Sucampo Pharmaceuticals, Inc. • Delaware
Contract Type FiledJune 19th, 2006 Company JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of May 26, 2004 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Michael J. Jeffries (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 19th, 2006 • Sucampo Pharmaceuticals, Inc. • Delaware
Contract Type FiledJune 19th, 2006 Company JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of May 26, 2004 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Ryuji Ueno (“Indemnitee”):
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 19th, 2006 • Sucampo Pharmaceuticals, Inc. • Delaware
Contract Type FiledJune 19th, 2006 Company JurisdictionINDEMNIFICATION AGREEMENT (this “Agreement”) dated as of May 26, 2004 by and between Sucampo Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Sachiko Kuno (“Indemnitee”):